Viralox
Recalling firm: APS BioGroup, Inc
The recall is being conducted as a result of elevated APC levels. Through additional testing, it was determined that the organism is Stenotrophomonas maltophilia.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Manufactured April 21, 2019. Lot 9068-2, Item # 4044, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-3, Item # 4691, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-4, Item # 4181, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-5, Item # 00064, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-6, Item # 00064, Bulk # UL-7, Exp. Date 04/2021
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Viralox, UPC 8 63784 00015 0. Immune Balancing Ploypeptide Oral Spray. 5.0 fl. oz. (150 ml) Oral Spray.
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 863784000150 | Viralox, UPC 8 63784 00015 0. Immune Balancing Ploypeptide Oral Spray. 5.0 fl. oz. (150 ml) Oral Spray. |
Recall details
- Recall number
- F-1479-2019
- Event ID
- 82900
- FDA status
- Terminated
- Initiated
- May 15, 2019
- Reported
- Jun 26, 2019
- Classified
- Jun 18, 2019
- Terminated
- Dec 27, 2019
- Quantity
- 7,132 Total Units
- Location
- Phoenix, AZ, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
Nationwide and Switzerland. No military/govt/VA consignees.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.